[ Inside the business ]

WAT stock analysis

WAT · Waters Corp

Laboratory analytical instruments. Growing 121%.

Nothing unusual in its latest filings.

The future, in 7 questions

Priced in: 3.1× sales in 5 yrs. Evidence: sales +121% · 5¢ profit/$1.

01 What's priced in?3.1× sales in 5 yrs
Sales now$5.6B
Needed in 5 yrs$17.5B
Backlog$463M
02 Is the wave rising?No Radar technology matched

Not among the companies mentioning Radar's technologies most.

03 Will customers keep buying?Pharmaceutical Customers: 59% of sales
Pharmaceutical Customers 59%Everyone else
Backlog $463M · under 0.1× salesPrepaid $561MSales +121%, speeding up
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Keeps 5¢ per $1, falling
'21'22'23'24'255¢
Before running costs: 58% → 59%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares +0.4%/yrDebt $4.5B
07 What could break it?1 to watch
  • Moves strongly with the S&P 500

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth speeding up.

Sales growth +91%, +113%, then +121% vs. a year ago.

What could go wrong

Few warning signs.

It has moved 1.0× the market. In the 2008 crisis it fell 54% while the market fell 51%. Debt is heavy.

Speculative check

Not classified.

Not Self-funding because of: debt over 4× operating profit.

What they sell

46% Consumables.

Consumables 46% · Instrument Systems 30% · Services 25% (latest quarter)

Where each dollar goes

Not available.

Cost lines aren't reported in a comparable form.

Its market

0.6× the economy.

The government expects its industry, navigational, measuring, electromedical, and control instruments manufacturing, to grow 1.1% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Maturity.

It earns cash, still invests, and pays back more than it borrows.

Earnings quality

Clean.

Its numbers don't resemble those of past manipulators. Cash covers 486¢ of each $1 of profit.

Competitive advantage

10 of 10 years.

Returns beat its 9.3% cost of capital in 10 of the last 10 years. Gross margin went from 59% to 59%.

Future bets

7% on research.

$371M a year on R&D. $189M on equipment and buildings.

All figures from Waters Corp's SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.